Literature DB >> 26671101

Risk factors for cognitive and functional change in one year in patients with Alzheimer's disease dementia from São Paulo, Brazil.

Fabricio Ferreira de Oliveira1, Glaucia Akiko Kamikado Pivi2, Elizabeth Suchi Chen3, Marilia Cardoso Smith4, Paulo Henrique Ferreira Bertolucci5.   

Abstract

Midlife cerebrovascular risk, low cognitive reserve and APOE4+ haplotypes are risk factors for Alzheimer's disease dementia (AD). We prospectively searched for factors that might be associated with yearly changes in caregiver burden, cognition, basic and instrumental functionality in 193 consecutive outpatients with late-onset AD, namely gender, APOE haplotypes, schooling, age at AD onset, marital status, depression, cerebrovascular risk factors, serum TSH levels, cognitive and physical activities, and treatment with cholinesterase inhibitors or anti-psychotics, while also investigating associations between APOE haplotypes and patient participation in cognitive or physical activities. Higher education led to greater declines in instrumental functionality, whereas increases in body mass index were associated with rises in basic functionality and cognitive test scores. Established cerebrovascular risk factors had no independent effects over cognitive or functional change, but their combinations led to cognitive improvement, possibly related to enhanced cerebral perfusion in late life. Cholinesterase inhibitors improved caregiver burden. Enhanced instrumental functionality and steeper cognitive decline by the use of anti-psychotics might be attributed to improved behavioural symptoms and neuropsychiatric side effects, respectively. Each copy of APOE-ε4 (β=-0.102) led to cumulative decreased participation in physical activities (ρ=0.015). These results might impact public health policies and the interpretation of clinical trials for AD.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Activities of daily living; Alzheimer disease; Cognition; Dementia; Educational status; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 26671101     DOI: 10.1016/j.jns.2015.10.051

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

2.  Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer's Disease.

Authors:  Jiajia Fu; Yan Huang; Ting Bao; Ruwei Ou; Qianqian Wei; Yongping Chen; Jing Yang; Xueping Chen; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

3.  Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Qing Cai; Jiangxia Wang; Mei-Cheng Wang; Abhay Moghekar; Michael I Miller; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2017-09-11       Impact factor: 4.673

4.  Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.

Authors:  Fabricio F de Oliveira; Elizabeth S Chen; Marilia C Smith; Paulo H Bertolucci
Journal:  Braz J Psychiatry       Date:  2017-01-12       Impact factor: 2.697

5.  Vascular cognitive impairment and dementia: An early career researcher perspective.

Authors:  Nárlon C Boa Sorte Silva; Oliver Bracko; Amy R Nelson; Fabricio Ferreira de Oliveira; Lisa S Robison; C Elizabeth Shaaban; Atticus H Hainsworth; Brittani R Price
Journal:  Alzheimers Dement (Amst)       Date:  2022-04-27

6.  Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.

Authors:  Fabricio Ferreira de Oliveira; Juliana Marília Berretta; Elizabeth Suchi Chen; Marilia Cardoso Smith; Paulo Henrique Ferreira Bertolucci
Journal:  Colomb Med (Cali)       Date:  2016-06-30

7.  Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.

Authors:  Fabricio Ferreira de Oliveira; Juliana Marília Berretta; Guido Veiga de Almeida Junior; Sandro Soares de Almeida; Elizabeth Suchi Chen; Marilia Cardoso Smith; Paulo Henrique Ferreira Bertolucci
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375

Review 8.  Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition.

Authors:  Patrick J Smith
Journal:  Brain Plast       Date:  2019-12-26

9.  Making the Best Out of IT: Design and Development of Exergames for Older Adults With Mild Neurocognitive Disorder - A Methodological Paper.

Authors:  Patrick Manser; Eling D de Bruin
Journal:  Front Aging Neurosci       Date:  2021-12-09       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.